Mortality Lower for Patients With Obesity and ARDS Receiving ECMO
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
THURSDAY, Aug. 31, 2023 -- Among patients with acute respiratory distress syndrome (ARDS) receiving extracorporeal membrane oxygenation (ECMO) support, obesity is associated with lower intensive care unit (ICU) mortality, according to a study published online Aug. 28 in the American Journal of Respiratory and Critical Care Medicine.
Darya Rudym, M.D., from New York University Langone Health in New York City, and colleagues examined the association between obesity and ICU mortality in patients with ARDS receiving ECMO in a large, retrospective cohort study. The study included 790 patients with ARDS receiving ECMO, of whom 320 had obesity.
The researchers found that 24.1 percent of patients with obesity and 35.3 percent of patients without obesity died in the ICU. Obesity was associated with lower ICU mortality in adjusted models (odds ratio, 0.63). In a multivariable regression analysis, higher body mass index was associated with lower ICU mortality when examined as a continuous variable (odds ratio, 0.97). In a propensity score-matched analysis of 199 patients with obesity and 199 patients without, patients with obesity had a lower probability of ICU death (22.6 percent) versus those without (35.2 percent).
"We hope that clinicians will consider the data from this study when making bedside decisions for ARDS patients with obesity instead of preemptively withholding this lifesaving therapy," Rudym said in a statement.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2023
Read this next
Small Differences in Weight Change With First-Line Antidepressants
MONDAY, July 1, 2024 -- For eight first-line antidepressants, small differences are seen in mean weight change, with the least weight gain with bupropion, according to a study...
Bariatric Surgery Tied to Lower Risk of MACE, Death in Obesity, Sleep Apnea
FRIDAY, June 28, 2024 -- Metabolic surgery is associated with significantly lower risk of major adverse cardiovascular events (MACE) compared with nonsurgical management among...
Exercise + GLP-1 RA Effective for Weight Loss While Preserving BMD
THURSDAY, June 27, 2024 -- For adults with obesity, without diabetes, combining exercise with the glucagon-like peptide-1 receptor agonist (GLP-1 RA), liraglutide, is effective...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.